Menopausal hormone therapy use and risk of primary liver cancer in the clinical practice research datalink

Oral contraceptives and menopausal hormone therapy: relative and attributable risks of cardiovascular disease, cancer, and other health outcomes

(2015) Shari S. Bassuk et al.   ANNALS OF EPIDEMIOLOGY

Reproductive factors, exogenous hormone use and risk of hepatocellular carcinoma among US women: results from the Liver Cancer Pooling Project

(2015) K A McGlynn et al.   BRITISH JOURNAL OF CANCER

Statin Use and Risk of Primary Liver Cancer in the Clinical Practice Research Datalink

(2015) K. A. McGlynn et al.   JNCI-Journal of the National Cancer Institute

Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies

(2015)   LANCET

Statin Use and Risk of Primary Liver Cancer in the Clinical Practice Research Datalink

(2015) K. A. McGlynn et al.   JNCI-Journal of the National Cancer Institute

Menopausal hormone therapy and central nervous system tumor risk: Large UK prospective study and meta-analysis

(2014) Victoria S. Benson et al.   INTERNATIONAL JOURNAL OF CANCER

Nonsteroidal Anti-inflammatory Drug Use, Chronic Liver Disease, and Hepatocellular Carcinoma

(2012) Vikrant V. Sahasrabuddhe et al.   JNCI-Journal of the National Cancer Institute

Menopausal hormone therapy and risk of gastrointestinal cancer: Nested case-control study within a prospective cohort, and meta-analysis

(2011) Jane Green et al.   INTERNATIONAL JOURNAL OF CANCER

Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: A systematic review and meta-analysis of cohort studies

(2011) Chenggang Wang et al.   INTERNATIONAL JOURNAL OF CANCER

Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma

(2010) Manal M. Hassan et al.   CANCER

Menopausal hormone therapy and risk of lung cancer—Systematic review and meta-analysis

(2009) Claudia M. Greiser et al.   MATURITAS